Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity
Xf. Le et al., Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity, ONCOGENE, 20(57), 2001, pp. 8258-8269
Heregulins are a group of growth factors that play diverse and critical rol
es in the signaling network of the human epidermal growth factor receptor (
HER or EGFR) superfamily. Our earlier studies have shown that recombinant h
eregulin beta1 (HRG) induces apoptosis in SKBr3 breast cancer cells that ov
erexpress HER2. Here we report molecular mechanisms of HRG-induced apoptosi
s. HRG treatment of SKBr3 cells for 72 h decreased the level of Bcl-2 prote
in. HRG treatment led to degradation of poly (ADP-ribose) polymerase (PARP)
and activated both caspase-9 and caspase-7. No significant activation of c
aspase-3, -6, or -8 was detected. Expression of exogenous caspase-7 by aden
ovirus-caspase-7 (Ad-casp-7) in SKBr3 cells resulted in apoptosis, which mi
micked the effect of HRG treatment. Expression of exogenous caspase-7 had n
o impact on Bcl-2 expression, but promoted PARP degradation. Two highly sel
ective inhibitors of protein kinase C (PKC), GF109203X (GF) and Ro318425 (R
o), significantly enhanced HRG-induced apoptosis as determined by flow cyto
metric analysis and DNA fragmentation assay. Accordingly, the PKC inhibitor
GF further decreased the level of Bcl-2 protein and further degraded PARP
in HRG-treated cells. Assay of PKC activity indicated that HRG activated PK
C in SKBr3 cells, predominantly affecting the PKC alpha isoform. To confirm
which PKC isoform(s) mediated potentiation of HRG-induced apoptosis, the p
rofile of PKC isoforms was measured in SKBr3 cells. Five PKC isoforms, PKC
alpha, PKCi, PKC zeta, PKC lambda, and PKC delta as well as their receptors
(RACK1) were expressed in this cell line. Treatment with PKC inhibitors GF
and Ro decreased protein levels of both PKC alpha and PKC delta at 24 h. P
KC alpha levels were still depressed at 72 h. GF and Ro had little effect o
n the expression of other PKC isoforms. An inhibitor of classical PKC isofo
rms (Go6976) enhanced HRG-induced apoptosis, whereas the PKC delta selectiv
e inhibitor rottlerin did not. As PKCa was the only classical isoform expre
ssed in SKBr3 cells, the effect of Go6976 on HRG-induced apoptosis largely
related to inhibition of PKCa. Constitutive expression of wild-type PKC alp
ha attenuated the apoptosis produced by HRG and GF. Consequently, HRG-induc
ed apoptosis in SKBr3 cells appeared to involve down-regulation of Bcl-2 pr
otein, activation of caspase-9 and caspase-7, and degradation of PARP. Inhi
bition of PKC function enhanced HRG-induced apoptosis, leading to synergist
ic down-regulation of Bcl-2 expression. Impairment of the PKC alpha isoform
alone was sufficient to potentiate HRG-induced apoptosis.